Protective Effect of Zingiber Officinale L. Extract in Hypertensive Patients

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

June 2, 2018

Study Completion Date

June 30, 2018

Conditions

The Main Focus of This Study is to Evaluate the Safety of Zingiber Officinale L. Tablets as Hypolipidemic Agent in Hypertensive Patients

Interventions

DRUG

Zingiber officinale L. tablets

Zingiber officinale L. tablets 500mg twice daily

DRUG

Simvastatin 20mg

Simvastatin 20mg once a day for 2 months

Trial Locations (1)

Alkhidmat Hospital, Karachi

All Listed Sponsors

collaborator

Al Khidmat Hospital Nazimabad Karachi

UNKNOWN

collaborator

Medics Laboratories (Pvt.) Ltd.

UNKNOWN

lead

Jinnah Sindh Medical University

OTHER

NCT05682911 - Protective Effect of Zingiber Officinale L. Extract in Hypertensive Patients | Biotech Hunter | Biotech Hunter